Table 3.
Distribution of responses relating to other types of pain (n = 73; distribution of physicians’ responses for each of the possible barriers to opioid use in the management of other types of pain (non-cancer/non-HIV/AIDS)).
| Not a problem | Minor problem | Moderate problem | Serious problem | Do not know | No response | |
|---|---|---|---|---|---|---|
| Prescription forms | 19 (26.02%) | 10 (13.69%) | 6 (8.21%) | 7 (9.58%) | 26 (35.61%) | 5 (6.84%) |
| Program licensing | 10 (13.69%) | 10 (13.69%) | 6 (8.21%) | 9 (12.32%) | 34 (46.57%) | 4 (5.47%) |
| Shortage of opioids | 16 (21.91%) | 10 (13.69%) | 5 (6.84%) | 10 (13.69%) | 28 (38.35%) | 4 (5.47%) |
| Physicians | 13 (17.80%) | 7 (9.58%) | 14 (19.17%) | 18 (24.65%) | 17 (23.28%) | 4 (5.47%) |
| Pharmacists | 4 (5.47%) | 6 (8.21%) | 6 (8.21%) | 16 (21.91%) | 36 (49.31%) | 5 (6.84%) |
| Nurses | 8 (10.95%) | 5 (6.84%) | 13 (17.80%) | 15 (20.54%) | 28 (38.35%) | 4 (5.47%) |
| Patients | 16 (21.91%) | 7 (9.58%) | 18 (24.65%) | 8 (10.95%) | 20 (27.39%) | 4 (5.47%) |
| Costs | 11 (15.06%) | 10 (13.69%) | 10 (13.69%) | 3 (4.10%) | 35 (47.94%) | 4 (5.47%) |
| Doses | 13 (17.80) | 13 (17.80%) | 9 (12.32%) | 7 (9.58%) | 27 (36.98%) | 4 (5.47%) |
| Regulations | 3 (4.10%) | 6 (8.21%) | 14 (19.17%) | 17 (23.28%) | 29 (39.72%) | 4 (5.47%) |
| Unavailable for home use | 4 (5.47%) | 9 (12.32%) | 12 (16.43%) | 19 (26.02%) | 25 (34.24%) | 4 (5.47%) |
| Physician licensing | 11 (15.06%) | 5 (6.84%) | 8 (10.95%) | 4 (5.47%) | 39 (53.42%) | 6 (8.21%) |